Dr. Andrew W. Pippas
Claim this profileJohn B Amos Cancer Center
Area of expertise
Breast Cancer
Andrew W. Pippas has run 6 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Andrew W. Pippas has run 6 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
John B. Amos Cancer Center
IACT Health
Clinical Trials Andrew W. Pippas is currently running
Nanosomal Docetaxel
for Triple Negative Breast Cancer
This trial tests a new, safer form of the cancer drug docetaxel, called Nanosomal Docetaxel Lipid Suspension (NDLS), in patients with advanced or spreading triple-negative breast cancer. NDLS aims to reduce side effects by using tiny fat particles. The drug works by stopping cancer cells from dividing and growing. Docetaxel is a widely used chemotherapy drug, and newer formulations like Nanosomal Docetaxel Lipid Suspension (NDLS) aim to improve its efficacy and reduce toxicity.
Recruiting
4 awards
Phase 3
13 criteria
Repotrectinib
for Solid Tumors
Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and recommended Phase 2 dose (RP2D) of repotrectinib given to adult subjects with advanced solid malignancies harboring an ALK, ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement. Midazolam DDI substudy will examine effect of of repotrectinib on CYP3A induction. Phase 2 will determine the confirmed Overall Response Rate (ORR) as assessed by Blinded Independent Central Review (BICR) of repotrectinib in each subject population expansion cohort of advanced solid tumors that harbor a ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement. The secondary objective will include the duration of response (DOR), time to response (TTR), progression-free survival (PFS), overall survival (OS) and clinical benefit rate (CBR) of repotrectinib in each expansion cohort of advanced solid tumors that harbor a ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement.
Recruiting
1 award
Phase 1 & 2
7 criteria
More about Andrew W. Pippas
Clinical Trial Related
9 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Andrew W. Pippas has experience with
- Pembrolizumab
- Prednisone
- Repotrectinib (TPX-0005)
- EndoPredict®
- Ladiratuzumab Vedotin
- Nanosomal Docetaxel Lipid Suspension
Breakdown of trials Andrew W. Pippas has run
Breast Cancer
Breast cancer
Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew W. Pippas specialize in?
Andrew W. Pippas focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are Stage IV.
Is Andrew W. Pippas currently recruiting for clinical trials?
Yes, Andrew W. Pippas is currently recruiting for 4 clinical trials in Columbus Georgia. If you're interested in participating, you should apply.
Are there any treatments that Andrew W. Pippas has studied deeply?
Yes, Andrew W. Pippas has studied treatments such as Pembrolizumab, Prednisone, Repotrectinib (TPX-0005).
What is the best way to schedule an appointment with Andrew W. Pippas?
Apply for one of the trials that Andrew W. Pippas is conducting.
What is the office address of Andrew W. Pippas?
The office of Andrew W. Pippas is located at: John B Amos Cancer Center, Columbus, Georgia 31904 United States. This is the address for their practice at the John B Amos Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.